Preparing tetraazacyclododecane-tetraacetic acid for applying in formulation of active pharmaceutical ingredients especially magnetic resonance imaging contrast agents, comprises treating tetraazacyclododecane-tetraacetic acid with inorganic acid, crystallizing, and precipitating
2023-08-11
专利权人SOLARA ACTIVE PHARMA SCI LTD (SOLA-Non-standard)
申请日期2023-08-11
专利号IN202341054046-A
成果简介NOVELTY - Preparing DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) comprises (i) treating an aqueous solution of DOTA having 0.00-0.75 pH with an inorganic acid; (ii) crystallizing the salt of DOTA as a solid from the aqueous solution; (iii) recrystallizing the crystallized salt of DOTA in a mixture of organic solvent and water at a pH less than 0.75; (iv) preparing aqueous solution of the recrystallized salt of DOTA at 3.0-5.0 pH; (v) treating the prepared aqueous solution of salt of DOTA with anionic resin at 3.0-5.0 pH to obtain an aqueous solution of DOTA; and (vi) adding an organic solvent to the filtered aqueous solution of DOTA; and (vii) precipitating DOTA from the solution in solid form. USE - Method for preparing DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) for applying in formulation of active pharmaceutical ingredients especially magnetic resonance imaging contrast agents. ADVANTAGE - None given.
IPC 分类号A61K-047/58 ; A61K-049/10 ; C07C-227/42 ; C07C-229/26 ; C07D-257/02
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20859
专题中国科学院新疆生态与地理研究所
作者单位
SOLARA ACTIVE PHARMA SCI LTD (SOLA-Non-standard)
推荐引用方式
GB/T 7714
NAMBIAR S,SIVADAS A,NARAYANAN D,et al. Preparing tetraazacyclododecane-tetraacetic acid for applying in formulation of active pharmaceutical ingredients especially magnetic resonance imaging contrast agents, comprises treating tetraazacyclododecane-tetraacetic acid with inorganic acid, crystallizing, and precipitating. IN202341054046-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。